Structure Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of innovative therapies targeting G protein-coupled receptors (GPCRs), which are essential in mediating various physiological processes and diseases

By leveraging advanced structural biology and computational techniques, the company aims to design small molecule treatments for a range of conditions, including metabolic disorders and neurodegenerative diseases. Through its research efforts, Structure Therapeutics strives to create effective and targeted therapeutics that can improve patient outcomes and contribute to advancements in personalized medicine.